ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
ARTELO BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Aug 20, 2026
$2.66−0.04 (-1.48%)
Close on Oct 19, 2026
- Market cap
- $7.21M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 31, 2026 | 1-for-9 reverse | Earlier per-share figures multiplied by 9 |
| Mar 10, 2026 | 1-for-3 reverse | Earlier per-share figures multiplied by 3 |
| Aug 13, 2025(first seen in filings) | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Jun 13, 2025 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Aug 10, 2022 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Jul 15, 2019(first seen in filings) | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |